Can a special yogurt boost iron in gestational diabetes?
NCT ID NCT07287384
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether a yogurt enriched with lactoferrin, a protein found in milk, could improve iron levels in 50 women with gestational diabetes. Half ate the special yogurt twice a day for two months, while the other half ate regular yogurt. The main goal was to see if the lactoferrin yogurt raised ferritin, a marker of iron stores, more than the plain yogurt.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lactoferrin-enriched yogurt
- What this could lead to
- If it works, this could point toward a simple dietary supplement to help manage iron status in women with gestational diabetes.
- What could go wrong
- This is a small pilot study with only 50 participants, so results may not be generalizable. The change in iron levels may be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of GDM confirmed by 75g glucose oral glucose tolerance test (OGTT). * Caucasian ethnicity, gestational age between 24 and 30 weeks. * Age \>18 and \<50 years. * Body Mass Index (BMI) between 22.5 and 35 kg/m². * Ability to provide informed consent to participate in the study. Exclusion Criteria: * Type 1 diabetes mellitus. * Allergies to milk proteins or lactose intolerance. * Known anemia. * Twin pregnancy. * Pre-existing iron supplementation exceeding 30 mg/day. * Insulin therapy at the time of enrollment. * Any condition or disease requiring specific dietary treatments. * Concurrent physical or mental conditions requiring pharmacological therapy * Autoimmune disorders.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gestational diabetes mellitus (GDM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Città della Salute e della Scienza di Torino, University of Torino, Torino.
Torino, Torino, 10126, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 40 weeks or 41? the delivery timing question for gestational diabetes
- Can a bedside ultrasound reveal hidden stomach contents before C-Section?
- Can olive oil and nuts in early pregnancy ward off gestational diabetes?
- Does a Mother's weight change the chemistry of her breast milk?
- Which pill tames pregnancy diabetes better?
- Weekly shot after gestational diabetes may shield new mothers from metabolic syndrome